Protection Against Visible Light by Dihydroxyacetone in Erythropoietic

Updated 06/21/2024

Status Recruiting

Clinical Trial Summary

What is the visible light protective effect of dihydroxyacetone in individuals with erythropoietic protoporphyria? This will be tested in this randomized blinded placebo controlled study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Erythropoietic Protoporphyria

Clinical Trial Details

NCT number	NCT05780840
Study type	Interventional
Source	Bispebjerg Hospital
Contact
Status	Recruiting
Phase	N/A
Start date	February 23, 2023
Completion date	September 2024

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00979745` - Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)	Phase 3
	Active, not recruiting	`NCT05308472` - Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP	Phase 2
	Completed	`NCT00004831` - Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria	N/A
	Completed	`NCT05572125` - Iron Therapy in Erythropoietic Protoporphyria
	Completed	`NCT01605136` - Phase III Confirmatory Study in Erythropoietic Protoporphyria	Phase 3
	Completed	`NCT01422915` - Sorbent Therapy of the Cutaneous Porphyrias	Phase 2/Phase 3
	Completed	`NCT04053270` - Multicentre Phase III Erythropoietic Protoporphyria Study	Phase 3
	Completed	`NCT00004940` - Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria	Phase 3
	Recruiting	`NCT06388642` - Pharmacokinetics of Afamelanotide in EPP Patients	Phase 1/Phase 2
	Recruiting	`NCT05020184` - Effect of Oral Cimetidine in the Protoporphyrias	Phase 2
	Completed	`NCT01688895` - Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
	Completed	`NCT04578496` - A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP)	Phase 3
	Recruiting	`NCT00206869` - Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria	N/A
	Completed	`NCT02979249` - Oral Iron for Erythropoietic Protoporphyrias	N/A
	Enrolling by invitation	`NCT05883748` - Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP	Phase 2/Phase 3
	Completed	`NCT01097044` - Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)	Phase 2
	Completed	`NCT03682731` - Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria